Clinical trials recruiting for Lung Neoplasms, Non-Small Cell Lung Cancer
3
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 3 1Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Osimertinib | 1 |
| a combined regimen consisting of double-dose third-generation EGFR-TKI, bevacizumab, and intrathecal chemotherapy in patients | 1 |
Self-screener
Recruiting trials
- Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study
- Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung Cancer
- Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer
Related conditions
Trials recruiting for Lung Neoplasms, Non-Small Cell Lung Cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Telerehabilitation 6Postoperative Complications 18Patient Reported Outcome Measures 4Leptomeningeal Metastasis 12Exercise Therapy 5
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Neoplasms, Non-Small Cell Lung Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.